We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

59 hedge funds and large institutions have $46.1M invested in Actinium Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

117% more capital invested

Capital invested by funds: $21.2M → $46.1M (+$24.9M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

6.2% more ownership

Funds ownership: 11.42% → 17.62% (+6.2%)

5% more funds holding

Funds holding: 56 → 59 (+3)

17% less call options, than puts

Call options by funds: $3.46M | Put options by funds: $4.18M

Holders
59
Holders Change
+3
Holders Change %
+5.36%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
9
Closed
8
Calls
$3.46M
Puts
$4.18M
Net Calls
-$712K
Net Calls Change
-$1.93M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.43M
2
BlackRock
BlackRock
New York
+$2.33M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2M
4
EI
EAM Investors
California
+$2M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.98M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$713K
2
JGC
J. Goldman & Co
New York
-$696K
3
Simplex Trading
Simplex Trading
Illinois
-$347K
4
Franklin Resources
Franklin Resources
California
-$153K
5
William Blair & Company
William Blair & Company
Illinois
-$148K
Name Holding Trade Value Shares
Change 		Change in
Stake
HBW
51
Hazlett, Burt & Watson
West Virginia
$2K – – –
Dimensional Fund Advisors
52
Dimensional Fund Advisors
Texas
$1.75K +$471K +46,404 +39%
Northwestern Mutual Wealth Management
53
Northwestern Mutual Wealth Management
Wisconsin
$1.14K – – –
TWA
54
TCI Wealth Advisors
Arizona
$1.06K – – –
Carson Wealth (CWM LLC)
55
Carson Wealth (CWM LLC)
Nebraska
$1K -$15.4K -1,522 -94%
GI
56
Gradient Investments
Minnesota
$703 – – –
TC
57
Truvestments Capital
Florida
$639 – – –
TCOV
58
Trust Company of Vermont
Vermont
$533 – – –
CS
59
Credit Suisse
Switzerland
$11 – – –
Franklin Resources
60
Franklin Resources
California
– -$153K -20,709 Closed
DU
61
Delphia (USA)
Ontario, Canada
– -$105K -14,226 Closed
CC
62
Corton Capital
Ontario, Canada
– -$103K -13,966 Closed
LSA
63
Leonteq Securities AG
Switzerland
– -$89.3K -12,000 Closed
EL
64
EMFO LLC
Florida
– -$12K -1,666 Closed
GFPC
65
Global Financial Private Client
Florida
– -$1.97K -266 Closed
RG
66
Retirement Group
California
– -$1K -79 Closed
1 2
3

ATNM Hedge Fund Activity: Q4 2022 in Review

59 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q4 2022, worth a combined $46.1M — up 117% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ATNM positions and 8 closed out — a net gain of 3 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $2.43M. The largest seller was Group One Trading, cutting an estimated $713K.

  • 59 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q4 2022, up from 56 in Q3 2022.
  • Funds reported $46.1M of Actinium Pharmaceuticals stock for Q4 2022, up 117% quarter-over-quarter.
  • 11 funds opened new Actinium Pharmaceuticals positions in Q4 2022 and 8 closed out, a net change of +3 holders.
  • The largest Actinium Pharmaceuticals buyer in Q4 2022 was D.E. Shaw & Co, an estimated $2.43M added.
  • The largest Actinium Pharmaceuticals seller in Q4 2022 was Group One Trading, an estimated $713K sold.

Based on aggregated 13F filings for Q4 2022.